Morten O A Sommer

About Morten O A Sommer

Morten O A Sommer, With an exceptional h-index of 60 and a recent h-index of 55 (since 2020), a distinguished researcher at Danmarks Tekniske Universitet, specializes in the field of Microbiology, Drug treatment, Metagenomics, Antibiotic Resistance, Synthetic biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Probiotic sulfation of secondary bile acids

Altering microbial populations & modifying microbiota

Engineered Escherichia coli Nissle 1917 Expressing IGF1 and FGF19 Reduce Liver Fat Accumulation and Restore Microbial Equilibrium in a Metabolic …

Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)

Reconstructing the transcriptional regulatory network of probiotic L. reuteri is enabled by transcriptomics and machine learning

Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice

Discovery of a Biotin Synthase That Utilizes an Auxiliary 4Fe–5S Cluster for Sulfur Insertion

Saccharomyces boulardii promoters for control of gene expression in vivo

Morten O A Sommer Information

University

Position

Professor

Citations(all)

14269

Citations(since 2020)

9539

Cited By

8407

hIndex(all)

60

hIndex(since 2020)

55

i10Index(all)

143

i10Index(since 2020)

133

Email

University Profile Page

Google Scholar

Morten O A Sommer Skills & Research Interests

Microbiology

Drug treatment

Metagenomics

Antibiotic Resistance

Synthetic biology

Top articles of Morten O A Sommer

Probiotic sulfation of secondary bile acids

2024/3/14

Altering microbial populations & modifying microbiota

2017/7/11

Engineered Escherichia coli Nissle 1917 Expressing IGF1 and FGF19 Reduce Liver Fat Accumulation and Restore Microbial Equilibrium in a Metabolic …

Proceedings

2024/3/8

Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)

Journal of the American Academy of Dermatology

2024/3/1

Reconstructing the transcriptional regulatory network of probiotic L. reuteri is enabled by transcriptomics and machine learning

Msystems

2024/2/13

Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice

Nature Biotechnology

2024/2

Discovery of a Biotin Synthase That Utilizes an Auxiliary 4Fe–5S Cluster for Sulfur Insertion

Journal of the American Chemical Society

2024/1/12

Saccharomyces boulardii promoters for control of gene expression in vivo

Microbial Cell Factories

2024/1/7

Is recombinant milk a better alternative for the environment?

2024

Cold exposure and oral delivery of GLP-1R agonists by an engineered probiotic yeast strain have antiobesity effects in mice

ACS Synthetic Biology

2023/10/12

Pangenome analysis reveals the genetic basis for taxonomic classification of the Lactobacillaceae family

Food Microbiology

2023

Drug-delivering bacteria

2023/9/21

Antimicrobial potential of class II bacteriocins on gut microbiota species

2023/8/28

Therapeutic microbes

2023/8/24

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy

Scientific Reports

2023/8/2

An integrated understanding of the metabolic benefits of a novel double-targeted genetically engineered probiotic expressing aldafermin intervention with dietary change on NAFLD

Atherosclerosis

2023/8/1

Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep

Pharmaceutical Research

2023/8

Physiology of Saccharomyces cerevisiae during growth on industrial sugar cane molasses can be reproduced in a tailor-made defined synthetic medium

Scientific Reports

2023/6/29

Formulation

2019

Treatment

2022/12/1

See List of Professors in Morten O A Sommer University(Danmarks Tekniske Universitet)

Co-Authors

academic-engine